Nalaganje...

Economic Evaluation of a Plerixafor for Stem Cell Mobilization

INTRODUCTION: Autologous peripheral stem cell transplantation (ASCT) with high-dose chemotherapy is a preferred treatment for relapsed non-Hodgkin’s lymphoma (NHL) patients. Estimated failure rates with current stem cell mobilization (SCM) regimens are 5% to 30%. Granulocyte colony-stimulating facto...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kymes, SM, Pusic, I, Lambert, DL, Gregory, M, Carson, KR, DiPersio, JF
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650087/
https://ncbi.nlm.nih.gov/pubmed/22435747
Oznake: Označite
Brez oznak, prvi označite!